Replies to post #59128 on SOHM Inc (SHMN)

[Myth]

give me an example, something that doesn't have to be verified by financials...

I'm talking about a sustained move up, not a " run " uphill then downhill....

[SLC-JD]

Fins showing continued incremental growth in profits/revs won't do much. The difference between $45k and $60k of revenue for the quarter just doesn't impact actual value with 1.5BB shares outstanding. Obviously, a major bump in revs/profits in and of itself should have some share price implications.

That said, I suspect that if the fins confirm that one or more of the prior announcements have been realized (irrespective of whether there is a significant impact to revs), people will start paying attention again, and we'll start to see a bit of speculative interest impacting PPS. Much moreso if the revs/profits leap forward.

[drugmanrx]

Not when put in it's proper perspective.

"Fins probably will not move the needle."

"In 2019, the average revenue for independent pharmacies was $3,400,000. That makes the average independent pharmacy gross profit $748,000?.Aug 29, 2018"

That is one lone independent pharmacy.

Then you get those that get all excited about a world pharmaceutical company doing $300,000 a year in revenue, just because the share structure hasn't changed.

Laughable